Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | +12.50% | -10.00% | -35.71% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 13.63M 18.64M 1.14B |
---|---|---|---|---|---|
Net income 2021 | -6M -8.2M -500M | Net income 2022 | -5M -6.83M -417M | EV / Sales 2021 | - |
Net Debt 2021 | 1.26M 1.73M 105M | Net Debt 2022 | 3.99M 5.45M 333M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.46
x | P/E ratio 2022 |
-2.41
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.85% |
Latest transcript on Hemostemix Inc.
1 day | +12.50% | ||
1 week | -10.00% | ||
Current month | -30.77% | ||
1 month | -30.77% | ||
3 months | -40.00% | ||
6 months | -47.06% | ||
Current year | -35.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Smeenk
FOU | Founder | - | 01/06/01 |
Christina Wu
DFI | Director of Finance/CFO | - | 05/20/05 |
Peter Pavlin
COO | Chief Operating Officer | - | 19/22/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Lacey
CHM | Chairman | 67 | 11/20/11 |
Ronnie Hershmann
BRD | Director/Board Member | - | 09/20/09 |
Thomas Smeenk
FOU | Founder | - | 01/06/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.045 | +12.50% | 32,000 |
25/24/25 | 0.04 | -11.11% | 353,200 |
24/24/24 | 0.045 | -10.00% | 82,500 |
22/24/22 | 0.05 | 0.00% | 20,000 |
19/24/19 | 0.05 | 0.00% | 111,000 |
Delayed Quote Toronto S.E., April 26, 2024 at 11:27 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.71% | 2.86M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- HEM Stock